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The microRNA pathway participates in basic cellular processes and its discovery has enabled the
development of si/shRNAs as powerful investigational tools and potential therapeutics. Based on a
simple kinetic model of the mRNA life cycle, we hypothesized that mRNAs with high turnover rates
may be more resistant to RNAi-mediated silencing. The results of a simple reporter experiment
strongly supported this hypothesis. We followed this with a genome-wide scale analysis of a rich
corpus of experiments, including RT–qPCR validation data for thousands of siRNAs, siRNA/
microRNA overexpression data and mRNA stability data. We ﬁnd that short-lived transcripts are
less affected by microRNA overexpression, suggesting that microRNA target prediction would be
improved if mRNA turnover rates were considered. Similarly, short-lived transcripts are more
difﬁcult to silence using siRNAs, and our results mayexplainwhycertain transcripts are inherently
recalcitrant to perturbation by small RNAs.
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Introduction
What determines how strongly an mRNA responds to a
microRNA or an siRNA? We know that properties of the
sequence match between the small RNA and the mRNA are
crucial. However, the same microRNA can repress different
mRNAs to varying orders of magnitude, with no noticeable
difference in features of the binding site (Lim et al, 2005;
Grimson et al, 2007). Similarly, different siRNAs that are
designed according to state-of-the-art guidelines will silence
their target mRNAs to different degrees. In part, this may
be explained by limitations in our understanding of small
RNA-targetrecognitionand theinﬂuenceofvarious contextual
features. However, large-scale validations of siRNA efﬁcacies
have shown that certain transcripts remain recalcitrant to
perturbation even after repeated redesign of the siRNA
(Krueger et al, 2007). Weak response to RNAi may thus be
an inherent property of the mRNA, but the underlying factors
have proven difﬁcult to uncover.
Progress has been made in identifying features, which help
predict the outcome of RNAi outside the speciﬁc micro/siRNA
binding site. These include the contribution of local sequence
context (Grimson et al, 2007), local RNA structure (Kertesz
et al, 2007; Long et al, 2007), RNA-binding protein (RBP)
motifs (Jacobsen et al, 2010), pre-existing endogenous micro-
RNA regulation (Khan et al, 2009) and total target cellular
abundance (Arvey et al, 2010). However, even taking these
factors into account still leaves puzzling discrepancies in what
we can explain or quantitatively predict.
siRNAs induce degradationbysequence-speciﬁc cleavage of
their target mRNAs (Elbashir et al, 2001). MicroRNAs, too,
induce mRNA degradation, and B80% of their effect on
protein levels can be explained by changes in transcript
abundance (Hendrickson et al, 2009; Guo et al, 2010). Given
that multiple factors act simultaneously to degrade individual
mRNAs, we here consider whether variable responses to
micro/siRNA regulation may, in part, be explained simply by
the basic dynamics of mRNA turnover. If a transcript is already
under strong destabilizing regulation, it is theoretically
possible that the relative change in abundance after the
addition of a novel degrading factor would be less pronounced
compared with a stable transcript (Figure 1). mRNA turnover
is achieved by a multitude of factors in addition to small
RNAs, such as those that act on AU-rich elements (AREs) and
other destabilizing RBPs, although the relative contributions
of these components are not known. The inﬂuence of
such factors on small RNA targeting can be individually
explored. However, their combined action, including yet
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mRNA decay rate.
mRNA decay rates in animal cells are highly variable, with
half-lives ranging from minutes to days (Ross, 1995). For
instance, for mRNAs in mouse embryonic stem cells the
median is around 7h, whereas some genes, including Foxa2,
Hes5 and Trib1, have half-lives under an hour (Sharova et al,
2009). We investigated the relationship between mRNA decay
rates, mRNA abundance and susceptibility to small RNA
perturbation using a mathematical model, a basic reporter
experiment and analysis of a rich corpus of large-scale
experiments, including RT–qPCR validation data for thou-
sands of siRNAs, siRNA/microRNA overexpression data and
mRNA stability data. Our theoretical analysis suggests that
short-lived transcripts could be more difﬁcult to perturb using
microRNAs and siRNAs, and this is consistently supported by
the experimental data.
Results
A basic model suggests a relationship between
turnover rate and targetability
First, weexploredthetheoreticalrelationship betweenthepre-
existing turnover rate of an mRNA, and its expected suscept-
ibility to perturbation by a small RNA. We assumed a basic
modelofthemRNAlifecycle,inwhichtherateoftranscription
is constant and the rate of degradation is described by
ﬁrst-order kinetics (see Materials and methods). We initially
assumed that pre-existing cell-endogenous factors (e.g. micro-
RNAs and RBPs) and an externally introduced or suddenly
upregulated factor (e.g., an siRNA or a microRNA) act
independently and contribute additively to the decay rate of
an mRNA. Under this model, the relative change in steady-
state expression level will become smaller as the pre-existing
decay rate grows larger, independent of the transcription rate
(Figure 2A). This relationship persists also if we assume
various degrees of synergy and antagonism between the pre-
existing factors and the external factor (described by an
interaction coefﬁcient q, see Materials and methods), with
increasing synergism leading totranscriptsbeing moreequally
targetable, regardless of their pre-existing decay rate. In this
model, the pre-existing decay rate is a property of the target
mRNA, while the introduced component describes the added
effect of a speciﬁc small RNA. We can thus expect the size of
the latter to be variable, and it is useful to think of the
pre-existing decay rate as a factor that limits rather than
determines the perturbation effect (Figure 2B).
Destabilization of a reporter transcript decreases
targetability
We next investigated the predicted relationship between pre-
existing mRNA stability and susceptibility to RNAi in a simple
experimental system. We generated a series of four luciferase
reporter constructs with destabilizing AREs of various
strengths incorporated into their 30 UTRs (Figure 3A). The
strongest ARE in this series reduced the reporter signal to 46%
compared with a non-destabilized construct (Figure 3B). This
conﬁrmed the activity of the AREs and corresponds to a 2.2-
foldincrease inturnoverrate(assumingconstant transcription
rates and translation efﬁcacies). To evaluate how the different
constructs would respond to perturbation, we performed co-
transfections with an siRNA targeted at the coding region of
the luciferase gene. This reduced the signal of the non-
destabilized construct to 26% comparedwith a control siRNA.
In contrast, the most destabilized construct showed 42%
remaining reporter activity compared with the control siRNA,
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Figure 1 Schematic illustration. The relative change in degradation rate after
perturbation of an mRNA by a small RNA will be different depending on the
pre-existing degrading effect.
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Figure 2 Theoretical variability in targeting efﬁcacy as a function the pre-
existing decay rate. (A) Various degrees of synergism and antagonism between
pre-existing mRNA decay rate and the added contribution of an introduced
degrading factor (e.g., an siRNA) were explored. The curves represent q¼0
(additive model), q¼ 1 (antagonistic), q¼ 2 (suppressive) and q¼1 and 5
(synergistic) (the interaction coefﬁcient q is described in Materials and methods).
(B) The exogenous component was randomized between 0 and 1 to describe
variation in efﬁcacy between different small RNAs (additive model).
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series (linear regression Po0.004, Figure 3C). Least-squares
ﬁtting of these results to our theoretical equations, based on
standardized turnover rates estimated from Figure 3B, re-
vealed that a weakly synergistic (q¼0.45) model gave the
closest ﬁt. However, this model was marginally better than the
additive case, and bootstrapping analysis showed that q was
not signiﬁcantly different from 0 (95% CI,  0.15 to 2.15)
(Figure 3C). In conclusion, we observed changes in the ability
of a reporter transcript to respond to siRNA perturbation (55%
increase in residual signal), caused by a relatively small (2.2-
fold) modulation of the turnover rate. mRNAs in the cell are
known to exhibit a considerably broader range of turnover
rates, motivating further investigation of this effect on real-
world transcripts.
High-turnover transcripts are more resistant
to silencing using siRNAs
We tested the relationship between the efﬁcacy of individual
siRNAs, as determined using thousands of RT–qPCR measure-
ments, and the turnover rates of their respective mRNA
targets. First, in order to determine turnover rates for
individual transcripts, we reanalyzed a microarray time series
of HeLa cells that were transcriptionally inhibited using
actinomycin D (Act D) (Iwamoto et al, 2008). Log2-trans-
formed mRNA decay proﬁles were ﬁt to a linear curve
y¼b1tþb0, where b1 is a decay rate coefﬁcient related to
half-life (t1/2¼ 1/b1, Figure 4A). Second, we analyzed a
previously unpublished set of 2622 siRNAs, for which
individual efﬁcacies were determined using RT–qPCR 48h
post-transfection in HeLa cells (Supplementary Table 1)
(www.appliedbiosystems.com). Of these, 1778 could be
associated with a decay rate as determined above. Indeed,
our results showed a relationship between the efﬁcacy of an
siRNA and the pre-existing turnover rate of the target
transcript. Although the overall correlation between the two
variables was modest (Spearman’s rank correlation rs¼0.22,
Po1e 20), we found that siRNAs directed at high-turnover
(t1/2o200min) and medium-turnover (200ot1/2o1000min)
mRNAs caused signiﬁcantly less repression than those
targeting long-lived (t1/241000min) transcripts (Po8e 11
and o4e 9, respectively, two-tailed KS-test, Figure 4B).
While 41.6% (498/1196) of the siRNAs directed at low-
turnover transcripts reached 10% remaining expression or
better, only 16.7% (31/186) of the siRNAs that targeted high-
turnover mRNAs reached this high degree of silencing
(Figure 4B). Reduced targetability (25.2%, 100/396) was also
seen for transcripts with medium turnover rate. We observed a
similar trend using RT–qPCRand RT–PCRmeasurementsfrom
87 si/shRNAs transfected into mouse embryonic stem cells
(Ren et al, 2006), conﬁrming these results in another cell type
and using an independent set of turnover rate measurements
(Sharova et al, 2009) (Supplementary Figure 1).
We expect to see variability in efﬁcacy among different
siRNAs directed at the same target, due to properties of the
siRNAs themselves. To account for this, we performed a gene
level analysisthat included only targetsfor which fouror more
siRNAs had been evaluated (n¼50). Most of these extensively
evaluated genes (40/50) could be silenced to 20% residual
expression or lower by one or more siRNAs, and more than
half (28/50) to 10%. However, a signiﬁcant correlation
between the two factors could still be observed (rs¼0.29,
Po0.05)andthisrelationshipappearedtogrowstrongerwhen
only considering genes for which ﬁve or six siRNAs had been
evaluated (n¼9, rs¼0.53, Po0.15, Figure 4C). Taken together,
these results show that high pre-existing mRNA turnover
rate is associated with reduced susceptibility to silencing by
siRNAs.
High-turnover transcripts are less inﬂuenced by
microRNAs overexpressed in HeLa and HepG2 cells
siRNAs typically induce strong silencing by cleavage of their
perfectly complementary targets, whereas microRNAs are
guided by imperfect complementarity to induce deadenylation
and subsequent degradation. On average, microRNAs have
a weaker variable effect on a larger set of transcripts, and due
to the limitations of microRNA target prediction not
all putative targets will be altered. Nevertheless, the mode
of action is similar enough to suggest that turnover rates could
also be important for microRNA targeting. We assembled
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Figure 3 Reporter experiments. (A) Schematic overview of luciferase reporter constructs harboring variable numbers of destabilizing (AUUU)n multimers (AREs) in
their30 UTRs.nvariedfrom1(non-functionalARE,‘DARE’)to7(potentARE).TokeepUTRlengthconstant,(AUUU)elementswereneverremovedbutratherreplaced
by non-functional (GUUU) elements (Zubiaga et al, 1995). (B) Relative luciferase signals from reporter constructs after transfection in HEK293 cells (normalized to
Renillaluciferase). (C) Co-transfections with a luciferase siRNA. Bars show reporter activities in siLuc-transfected cells relative to a control siRNA (siCtrl), and error bars
indicate s.e.m. (n¼3). b¼2.5% per (AUUU) repeat; 95% CI 1.2–3.7% using linear regression. White and gray bars show theoretically expected results (least-squares
ﬁtting) based on an additive (q¼0) and a weakly synergistic (q¼0.42) model (sum of squared errors¼0.021 and 0.018, respectively).
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microRNA transfections in HeLa cells (Supplementary Table 2)
and deﬁnedpredicted targets for these microRNAs. As expected,
in 17 out of the 20 data sets, predicted target mRNAs with
low turnover rates (as deﬁned above) had stronger average
repression than their high-turnover counterparts (Supplemen-
tary Figure 2). To quantify the effect, we pooled z-transformed
expression changes from all 20 experiments. We found that
predicted target mRNAs with short and medium half-life were
signiﬁcantly less repressed after transfection than their long-
lived counterparts (Po8e 5 and Po0.03, respectively, two-
tailed KS-test, Figure 5A). Speciﬁcally, 10.2% (293/2874) of
long-lived targets versus 4.4% (41/942) of short-lived targets
were strongly (z-score o 3) repressed.
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targets that were strongly repressed (z-score o 3). (B) Similar analysis based on a time series of miR-124 overexpression in HepG2 cells. Result shown is for 24h
after transfection. Source data is available for this ﬁgure at www.nature.com/msb.
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similar analysis using a microarray time series of miR-124
overexpression in HepG2 cells (Wang, 2006), which was also
the basis of a recent mRNA decay modeling study (Vohradsky
et al, 2010). These data were combined with published decay
rates for 3600 genes in the same cell line (Yang et al, 2003).
Predicted targets with high turnover rates were more strongly
affected, both in the early response after transfection (8 and
16h) and at the end of the time series (120h, Supplementary
Figure 3). At 24h, none of the predicted targets with high-
turnover rates (t1/2o200min) were repressed more than  1.5
log2, while 13% of predicted targets with t1/241000min
reached this level (Po0.02, Figure 5B).
High-turnover transcripts are more resistant
to siRNA off-target effects
siRNAsareknowntocause off-target effectsthataremediated,
in part, by microRNA-like seed complementarity (Jackson
et al, 2006). Our results indicate that mRNA turnover rates
could also inﬂuence seed-mediated off-target regulation. To
investigate this, we analyzed changes in transcript levels after
transfection of seven different siRNAs, each with a unique
seed region (Jackson et al, 2006). Z-transformed expression
changes from all seven experiments were pooled, and putative
‘off-targets’ wereidentiﬁed by mapping of non-conserved seed
matches in 30 UTRs. We found that low-turnover mRNAs (t1/2
41000min) were more affected by seed-mediated off-target
silencing than high-turnover mRNAs (t1/2o200min), with
twice as many long-lived seed-containing transcripts (3.8
versus 1.9%) being strongly (z-score o 3) repressed (Sup-
plementary Figure 4).
Relationship between mRNA turnover rate, mRNA
abundance and targetability
mRNA turnover rate is intimately coupled to mRNA abun-
dance, as the steady-state levels of mRNAs having the same
rate of transcription will be completely determined by their
decay characteristics. We observed a modest but signiﬁcant
correlation (rs¼ 0.23, Po1e 20) between decay rate and
abundance, indicating that abundance could have a predictive
value on targetability (Supplementary Figure 5A). Indeed, we
observed a negative correlation between target mRNA level
and relative level after siRNA transfection (rs¼ 0.24,
Po1e 20, Supplementary Figure 5B). Other factors related
to mRNA turnover rate, such as UTR length and the number of
conserved target sites for highly expressed microRNAs, were
only weakly associated (rs¼0.07 and 0.11, respectively). In
contrast to turnover rate, the association between abundance
and targetability became weaker when we considered the best
siRNA out of several tested against the same gene (rs¼ 0.20
and  0.10 for four or ﬁve to six siRNAs, respectively,
Supplementary Figure 5C). It should be noted that abundance
here refers to the level of the target transcript, as opposed to
previous work investigating the inﬂuence of the total
abundance of competing targets in the cell (Arvey et al, 2010).
To assess whether turnover rate and abundance contributed
independently to targetability, we combined the two using
multiple linear regression on the full set of siRNAs (n¼1778).
Both were found to contribute signiﬁcantly (bhalf-life¼0.16;
95% CI 0.12–0.21, babundance¼ 0.23; 95% CI  0.28 to  0.19),
as we observed an increased correlation for the complete
model compared with abundance or turnover rate alone
(rs¼0.31, determined leave-one-out cross-validation). The
model was not further improved by incorporating UTR
lengthandconservedsitesasadditionalfeatures.Interestingly,
despite an overall correlation between abundance and
targetability, mRNAs with high turnover rate remained
difﬁcult to repress regardless of their steady-state levels:
siRNAs were divided into three bins based on their target
mRNA levels (low, medium and high abundance; n¼714, 806
and 258, respectively, Figure 6). For siRNAs targeting genes
with t1/2o200min, strong repression (o10% residual
expression) was seen in only 18.0, 16.3 and 20.0% of the
cases, respectively. In comparison, 28.3, 40.4 and 57.7% of
siRNAs targeting genes with t1/24200min reached this level
(Figure 6).
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information, with high abundance being associated with
higher targetability. However, in accordance with our theore-
tical model, high turnover rate is associated with limited
targetability also in the case of abundant transcripts.
Discussion
Starting with a basic model of the mRNA life cycle, we
predicted that the pre-existing turnover rate of an mRNA
should inﬂuence its susceptibility to perturbation by small
RNA molecules. Assuming constant transcription rate, the
relativemRNAlevelchangewilldependontherelativeandnot
the absolute change in degradation rate. A simple experiment
showed that introduction of destabilizing elements to a
reporter transcript leads to attenuated siRNA silencing.
Although our interpretation of the model was based on
steady-state solutions and the reporter experiment represents
a dynamic situation, the outcome was close to the expectation
underamodelwhereendogenousdestabilizingfactorsandthe
exogenous agent (the siRNA) contribute additively to decay
rate of the transcript.
We then present several independent lines of evidence for
the inverse relationship between mRNA decay rates and
susceptibility to small RNA perturbation on a genome-wide
scale.TheanalysisofqPCR-basedsiRNAvalidationdatashows
that real-world high-turnover transcripts are more resistant to
siRNA silencing. The correlation between achieved silencing
and turnover rate is substantially stronger, if we only consider
the most effective siRNA designed against a particular gene.
Given that siRNA molecules cannot be inﬁnitely efﬁcient and
that their concentrations during delivery must be kept within
certain limits, this suggests that that as other aspects of siRNA
targeting improve, we approach an upper bound to the level of
silencing that can be achieved for any given turnover rate. The
limitations may thus not be in the design of the molecule, but
rather inherent to the target as a whole. This should reduce
expectations and clarify observed inconsistencies between
different levels of repression achieved. Our observations are
consistent with a recent report, suggesting that unknown
target-inherent factors may limit siRNA efﬁcacy for certain
genes(Kruegeretal,2007).Theseincludedtwokinases,DGKE
and ARHGAP27, which could not be efﬁciently silenced in
HeLa cells, despite evaluation of 18 unique siRNAs. Interest-
ingly, t1/2 for these genes is short (309 and 511min,
respectively), probably explaining the observed low efﬁcacy.
Differences in mRNA half-life may also explain why reporter
vectors, containing cloned target sites, tend to be more
efﬁciently silenced than the corresponding endogenous
targets. Still, our analysis also shows that low turnover rate
doesnotguaranteestrongrepression,andcontinuedsearchfor
additional transcript-inherent properties that modulate RNAi
susceptibility is therefore motivated.
We additionally observed that high transcript abundance
was associated with high susceptibility to repression by
siRNAs. This is intriguing as two earlier studies failed to show
such a relationship (Krueger et al, 2007; Guo et al, 2010).
AlthoughweobservedasimilareffectformicroRNAs(datanot
shown), it is in this case possible that fold changes of low-
abundance transcripts could be compressed due to the limited
signal-to-noise ratio of microarrays (Evans et al, 2003). A
related technical explanation cannot be excluded for our
siRNA analysis, but it seems less likely as it was based on
RT–qPCR measurements, which have considerable dynamic
range (Heid et al, 1996). Interestingly, the most abundant
transcripts were usually associated with low turnover rates,
althoughatechnicalartifactcannotbeexcluded(e.g.,ﬂattened
decaycurvedue to saturation on the microarray). Importantly,
however, abundant transcripts associated with high-turnover
rates still remained difﬁcult to repress,and multiple regression
wasusedtoshowthatthetwofactorscontributedindependent
information about targetability. We also noted that the
correlation between abundance and targetability was reduced
when only considering the best out of four to six siRNAs
designed against the same gene. In conclusion, abundance
contributes additional information about targetability. How-
ever, whereas a simple model can explain the relationship
between decay rate and targetability, the mechanism is less
clear in the case of target abundance, and our results call for
further investigation.
Modiﬁed siRNAs are being developed for therapeutic use,
for instance in lowering LDL-cholesterol by targeting of APOB
andPCSK9(Zimmermannet al,2006;Frank-Kamenetskyet al,
2008).Onthewhole,mRNAsdisplayawiderangeofstabilities
in any given physiological condition, and different functional
groups tend to have distinct, conserved half-life proﬁles (Yang
et al, 2003). It follows therefore, that some groups of genes are
more likely to be targetable by siRNAs than others. For
instance, metabolic related genes (with low-turnover mRNAs)
may be more targetable than apoptosis-related genes (Cheadle
et al, 2005) and transcription factors (Yang et al, 2003), which
tend to have shorter half-lives. For future choices of
therapeutic targets in pathways of interest, mRNA half-life
could be one factor to consider, as it may be beneﬁcial to avoid
inherently recalcitrant targets and instead focus of long-lived
transcripts that are more likely to respond to perturbation.
This may also allow the therapeutic index to be increased.
We also show that siRNA off-target effects, mediated by seed
complementarity, are more frequently seen on transcripts
with low-turnover rates, thus suggesting that selecting seed
sequences that preferably match high-turnover transcripts
may reduce these effects.
microRNA target prediction typically involves sequence
analysis to identify putative target sites, and the predicted
strength of the interaction is judged from properties of the site
oritsimmediatesequencecontext(Johnetal,2004;Grunetal,
2005; Hammell et al, 2008; Friedman et al, 2009). When we
analyzed genome-wide transcript level changes after micro-
RNA overexpression, we found a relationship between the
turnover rates of predicted target mRNAs and the extent to
which they were repressed. The chance of observing strong
repression was reduced by B50% for short-lived predicted
targets compared with long-lived predicted targets. Recent
work has suggested a move away from the binary distinction
between mRNAs as ‘targets’ or ‘non-targets’, toward a more
context-dependent and quantitative approach (Seitz, 2009;
Arvey et al, 2010; Poliseno et al, 2010). Our work supports this
view, inwhich an mRNA in one cell type may not be targetable
by a microRNA or siRNA to the same extent in another cell
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context. This suggests that future microRNA target prediction
algorithms should beneﬁt from the use of system-level
properties such as pre-existing decay rates. We estimate that
B11% of all genes expressed in HeLa cells have half-lives
below 200min, a ﬁgure that is likely translatable to other cells
types, and speciﬁcally show that this category of genes is
difﬁculttoperturbusingRNAi.Althoughthisrepresentsonlya
small fraction of the transcriptome, it still means that over
2000 protein-coding genes may be inherently more difﬁcult to
repress due to their high turnover rates.
In summary, mRNA turnover rates have an important
inﬂuence on the changes exerted by small RNAs on mRNA
levels. It can be assumed that mRNA half-lives will inﬂu-
ence how mRNAs are differentially perturbed whenever small
RNA levels change in the cell, not only after transfection
but also during differentiation, pathogenesis and normal cell
physiology.
Materials and methods
A basic model of mRNA turnover
We wanted to theoretically clarify the relationship between the
pre-existing turnover rate of an mRNA, and its expected susceptibility
to perturbation by a small RNA molecule. To do this, we assumed a
basicmodelofthemRNAlifecycle,inwhichtherateoftranscriptionis
constantandtherateofdegradationisdescribedbyﬁrst-orderkinetics.
In a generalized form of this model, the derivative of the abundance of
an mRNA can be described as
. y ¼ a   fðm; MÞy
where a is the rate of transcription and f(m, M) is the combined
contributions of endogenous factors (m) and an externally introduced
factor (M) to the (speciﬁc) decay rate. If we assume additivity and
independence, f would be simply the sum of the two factors. However,
there are speciﬁc known cases of siRNAs and microRNAs acting in
synergy (Vella et al, 2004; Grimson et al, 2007; Saetrom et al, 2007).
It also cannot be excluded that the accumulated action of a multitude
of heterogeneous degrading factors on an mRNA would, on average,
eventually exhibit an antagonistic effect, because of, e.g., steric
competitionforaccesstothemRNAorﬂuxlimitationsinthemolecular
components involved in degradation. To explore synergism and
antagonism, we deﬁned f as:
fðm; M; qÞ¼maxðm þ M þ mMq;0Þ
By modulating q, this function can be tuned to describe additive,
synergistic, antagonistic and even suppressive interaction, where the
addition of a second factor releases the effect of the ﬁrst (Bollenbach
et al, 2009) (Supplementary Figure S5). Steady-state equilibrium
(y?¼0) is reached when
y0 ¼ a=fðm; M; qÞð 1Þ
The relative abundance after introduction of an external destabilizing
agent M can be therefore be described as
R ¼
a=fðm; M; qÞ
a=fðm; 0; qÞ
¼
fðm; 0; qÞ
fðm; M; qÞ
ð2Þ
or, for the special case of additivity,
R ¼
a=ðm þ MÞ
a=m
¼
m
m þ M
ð3Þ
As the rate of transcription is eliminated, it does not inﬂuence
susceptibility to perturbation under this basic model. The endogenous
decay rate m must be larger than zero, or the mRNAwould accumulate
indeﬁnitely in the unperturbed cell.
We now explored how the relative abundance after perturbation,
R, varies with m, for simplicity using a ﬁxed value for the exogenous
component (M¼1) (Figure 2A). As expected from Equation (3), the
sizeoftheperturbationbecomeslesspronouncedasm(thepre-existing
endogenous degradation rate) grows large relative to M (the externally
introducedperturbation)underapurelyadditivemodel.Anantagonistic
behavior will make this relationship stronger. Increasing synergism, on
the other hand,willmaketranscriptsmore equallytargetable, regardless
of their endogenous decay rate.
Luciferase assays
Adestabilizing(AUUU)7multimerelement(ARE)(Zubiagaetal,1995)
was cloned into the 30 UTR of the pEZX-MT01 SV40-ﬁreﬂy luciferase
reporter vector (Genecopoeia). Three mutated variants of this
construct were generated, where 2, 4 or 6 of the adenosines were
replaced by guanosines, the last representing a completely inactivated
ARE. In addition, all constructs contained an identical 60bp fragment
fromthemouseFli130 UTR(Larssonetal,2009).Clonedsequencesare
listed in Supplementary Table 3 (mutations are indicated in bold).
HEK293 cells, 25000 per well, were seeded onto 24-well plates and
cultured overnight in DMEM (10% FCS) without antibiotics. Co-
transfections were performed using Lipofectamine 2000 (Invitrogen),
according to the manufacturers instructions, and using 75ng of
plasmid DNA and 10pmol of a custom siRNA directed against the
codingregionoftheluciferasegene(siLuc)oranegativecontrolsiRNA
(AM4636, Applied Biosystems). Fireﬂy luciferase activity was assayed
using the Dual-Luciferase Reporter System (Promega) after 52h.
Signals were normalized to the activity of the CMV-Renilla luciferase
gene, which is built into pEZX-MT01.
Least-squares ﬁtting
Based on Equation (1), and assuming turnover rates and translation
efﬁcacies to be constant, pre-existing turnover rates (m) of the four
constructs were estimated as 1/y, where y represents the reporter
signal (0.47, 0.51, 0.75 and 1.00 on a standardized scale). We
minimized the ﬁt (sum of squared errors) of Equation (2) to the
observed relative levels in Figure 3C, with the exogenous component
Mandtheinteractioncoefﬁcientqbeingthetwounknownparameters.
Due to the low dimensionality, this was done using exhaustive search
of the solution space at high resolution. A bootstrapping strategy was
applied to determine whether q was signiﬁcantly different from 0. The
observed luciferase data was resampled 1000 times with replacement
and with the same sample size as the original data, and least-squares
ﬁtting of the model was performed on each sample. A 95% conﬁdence
interval was estimated by determining the 2.5th and 97.5th percentiles.
Determination of mRNA half-lives in HeLa cells
mRNA half-lives (t1/2) were determined by reanalysis of a 120-min,
ﬁve time point, microarray (Affymetrix U133v2) time series of
HeLa cells that were transcriptionally inhibited using Act D (Iwamoto
et al, 2008). The arrays were annotated using gene-probeset mappings
from the ENSEMBL database (Birney et al, 2004). Probesets mapping
to more than one ENSEMBL gene were removed and probesets
associated with the same gene were averaged, resulting in a ﬁnal
dataset covering 17849 unique ENSEMBL genes. Log2-transformed
intensity values for each gene were ﬁt to a linear curve y¼b1tþb0,
corresponding to an exponential decay model, where b0 is the initial
intensitywhenActDisaddedandb1isadecaysloperelatedtohalf-life
(t1/2¼ 1/b1). Genes with a poor ﬁt to this model (sum-of-squared
errors 40.5) and genes with low expression in HeLa cells (signal
intensity o100) were removed, eventually resulting in b1 coefﬁcients
being reliably determined for 8211 genes. Intensity values before Act D
treatment (time point 0) were used as measurements of mRNA
abundances in HeLa.
siRNA qPCR validation data
Overall, 4481 RT–qPCR measurements in HeLa (SYBR green or
Taqman) for 2622 human Silencer
s siRNAs covering 1105 unique
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com). Replicate measurements (log2scale) were averaged to produce one
measure per unique siRNA. Half-life data, as described above, were
available for 735 of these genes.
Assembly of microarray experiments from public
repositories
We assembled microarray data from 20 microRNA-mimic overexpres-
sion experiments (Lim et al, 2005; Grimson et al, 2007; He et al, 2007;
Linsley et al, 2007; Selbach et al, 2008; Gennarino et al, 2009)
(Supplementary Table 2) and 7 siRNA overexpression experiments
(Jacksonetal,2006)(MAPK14-1y7),allperformedinHeLacells.The
20 microRNAexperiments were selected to represent a non-redundant
set of microRNA families. In cases where we could identify more than
one data set for the same microRNA family, the one showing the
strongest regulation (as determined using the two-sample KS-test) of
predicted targets versus remaining genes was selected. Redundant
probes were averaged. Predicted targets were identiﬁed by mapping of
microRNAandsiRNAseedregionsasdescribedpreviously(Khanetal,
2009), requiring evolutionary conservation across four mammalian
species for microRNAs and requiring presence of two non-conserved
seed matches for siRNAs. Conserved sites for microRNAs with high
endogenous expression was identiﬁed as described previously (Khan
et al,2009), inbriefbasedonthe 10mostabundantmicroRNAfamilies
in HeLa.
Multiple regression
We applied multiple linear regression, using least-squares minimiza-
tion, as implemented in the Matlab Statistics Toolbox (Mathworks
Inc.). The two predictor variables (turnover rate and mRNA
abundance), as well as the response variable (log2 relative target
mRNA level after siRNA transfection), were standardized by adjusting
their means and standard deviations to 1. We employed leave-one-out
cross-validation (n¼1778) to assess whether the combined model had
higher predictive power (as determined by Spearman’s rank correla-
tion rs) than either variable alone.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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